Recurrent Adult Immunoblastic Large Cell Lymphoma Withdrawn Phase Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01769911Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaTreatment